HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Mondrian Investment Partners LTD

Mondrian Investment Partners LTD reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 358,005 shares of the company’s stock after selling 7,423 shares during the period. HCA Healthcare makes up approximately 2.0% of Mondrian Investment Partners LTD’s holdings, making the stock its 25th largest holding. Mondrian Investment Partners LTD’s holdings in HCA Healthcare were worth $118,109,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. Evergreen Private Wealth LLC boosted its position in HCA Healthcare by 0.3% during the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after acquiring an additional 35 shares during the period. First Horizon Advisors Inc. raised its stake in shares of HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after buying an additional 36 shares in the last quarter. Mediolanum International Funds Ltd raised its stake in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after buying an additional 36 shares in the last quarter. Hartford Funds Management Co LLC raised its stake in shares of HCA Healthcare by 1.6% in the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock worth $1,003,000 after buying an additional 39 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. raised its stake in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after buying an additional 40 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $314.71 on Friday. The business’s 50-day moving average price is $318.53 and its two-hundred day moving average price is $346.05. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market capitalization of $77.48 billion, a P/E ratio of 14.32, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the company earned $5.90 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.92%. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 13.11%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on HCA shares. Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.